The Future of At-Home Diagnostics with Nanowear CEO & Co-Founder Venk Varadan
Wed Jan 07 2026
Most wearables track one thing at a time: steps, sleep, heart rate. Nanowear is building something entirely new: a single piece of fabric that acts like a full physical exam whenever you wear it.
CEO and co-founder Venk Varadan started the company nearly ten years ago with his father, Dr. Vijay Varadan, after discovering a breakthrough textile that can read the body without adhesives or multiple devices. One fabric-based sensor captures heart, lungs, blood pressure, respiration, and metabolic signals all at once; nothing on the market can do that today.
Rather than rushing a consumer launch, Venk spent years doing the hard part: FDA clearances, clinical validation, and building the infrastructure so Nanowear’s technology could plug into virtual care platforms, employer health plans, and connected devices people already use.
The long-term vision? Over-the-counter diagnostic kits anyone can use at home, real, clinical-grade data you can take straight to your doctor.
The path has been long: years of R&D, tough fundraising cycles, and a market that wasn’t ready for a category this big. But Venk never lost sight of the mission.
“If we don’t build this, it’s not going to happen.”
Next up: a 2026 rollout, employer-led prevention programs, and eventually global access, especially for people far from consistent medical care.
A decade in, Nanowear remains a rare founder story: slow, disciplined, and quietly building the future of diagnostics.
More
Most wearables track one thing at a time: steps, sleep, heart rate. Nanowear is building something entirely new: a single piece of fabric that acts like a full physical exam whenever you wear it. CEO and co-founder Venk Varadan started the company nearly ten years ago with his father, Dr. Vijay Varadan, after discovering a breakthrough textile that can read the body without adhesives or multiple devices. One fabric-based sensor captures heart, lungs, blood pressure, respiration, and metabolic signals all at once; nothing on the market can do that today. Rather than rushing a consumer launch, Venk spent years doing the hard part: FDA clearances, clinical validation, and building the infrastructure so Nanowear’s technology could plug into virtual care platforms, employer health plans, and connected devices people already use. The long-term vision? Over-the-counter diagnostic kits anyone can use at home, real, clinical-grade data you can take straight to your doctor. The path has been long: years of R&D, tough fundraising cycles, and a market that wasn’t ready for a category this big. But Venk never lost sight of the mission. “If we don’t build this, it’s not going to happen.” Next up: a 2026 rollout, employer-led prevention programs, and eventually global access, especially for people far from consistent medical care. A decade in, Nanowear remains a rare founder story: slow, disciplined, and quietly building the future of diagnostics.